Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A3316 Clemizole hydrochlorideTarget: Histamine H1 Receptors|TRPC channelSummary: H1 histamine receptor antagonist
- A8200 DAPT (GSI-IX)6 CitationSummary: γ-secretase inhibitor,potent and specific
- A1112 Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial CellSummary: Blocker of NO production
- A4013 Aspirin (Acetylsalicylic acid)Summary: Cyclooxygenase (COX) inhibitor
- A1114 Parathyroid Hormone (1-34), bovineSummary: Enhancer of blood calcium level
- A1134 Agouti-related Protein (AGRP) (25-82), humanTarget: Melanocortin (MC) ReceptorsSummary: Agouti-related peptide(25-82)
- A1932 (-)-Huperzine ATarget: NMDA Receptors|AChESummary: NMDA receptor antagonist/AChE inhibitor
- A2700 10Panx1 CitationTarget: Gap JunctionsSummary: Panx-1 mimetic inhibitor
- A2701 Scrambled 10PanxSummary: Panx-1 mimetic inhibitory peptide, blocks pannexin-1 gap junctions
- A3136 A-740003Target: P2X ReceptorsSummary: P2X7 receptor antagonist